Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications

Abstract

Extracellular vesicles (EVs), involved in essential physiological and pathological processes of the organism, have emerged as powerful tools for disease treatment owing to their unique natural biological characteristics and artificially acquired advantages. However, the limited targeting ability, insufficient production yield, and low drug‐loading capability of natural simplex EVs have greatly hindered their development in clinical translation. Therefore, the establishment of multifunctional hybrid membrane nanovesicles (HMNVs) with favorable adaptability and flexibility has become the key to expanding the practical application of EVs. This timely review summarizes the current progress of HMNVs for biomedical applications. Different HMNVs preparation strategies including physical, chemical, and chimera approaches are first discussed. This review then individually describes the diverse types of HMNVs based on homologous or heterologous cell membrane substances, a fusion of cell membrane and liposome, as well as a fusion of cell membrane and bacterial membrane. Subsequently, a specific emphasis is placed on the highlight of biological applications of the HMNVs toward various diseases with representative examples. Finally, ongoing challenges and prospects of the currently developed HMNVs in clinical translational applications are briefly presented. This review will not only stimulate broad interest among researchers from diverse disciplines but also provide valuable insights for the development of promising nanoplatforms in precision medicine.

Plant‐derived nanovesicles offer a promising avenue for anti‐aging interventions

“…In biomedical research, there is a subsection of scientists currently developing innovative, multifunctional fusion nanovesicles (FVs) (Sun et al 2023). These are specifically designed to target lesions and are a promising avenue for treating various autoimmune skin diseases.…”

Unveiling the power of microenvironment in liver regeneration: an in-depth overview

“…In addition to protein molecules, sphingosine-1-phosphate, prostaglandin E2, and serotonin are also involved in the regulation of LR ( Ding et al, 2016 ; He et al, 2019 ; Cheng et al, 2021 ). Extracellular vesicles represent another form of mediating communication between cells ( Brandel et al, 2022 ), and due to their accessibility, extracellular vesicles have become an important approach for the diagnosis and treatment of various diseases ( Sun et al, 2023 ). After liver resection, extracellular vesicles produced by hepatocytes can stimulate the production of neutrophils and release cytokines such as HGF, promoting LR ( Brandel et al, 2022 ).…”

Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes

“…Based on similarity-miscibility theory, this similarity suggests feasibility for membrane fusion between liposomes and NK-EVs. The integration of NK-EVs with liposomes offers a “1 + 1 > 2” synergistic effect. , This not only compensates for the limited drug loading capacity and uncontrollable drug loading process of exosomes but also endows the hybrid liposomes with the active targeting function of EVs, enabling BBB and BBTB traversal. Subsequently, drug release occurs, enhancing nanoparticle penetration into tumor tissues and minimizing cytotoxic effects and hypersensitivity reactions associated with liposomes.…”